Your browser doesn't support javascript.
loading
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma.
Castillo-Ferrer, Camila; Marguet, Théo; Vanwonterghem, Laetitia; Erbek, Sule; Chuffart, Florent; Mouret, Stéphane; Messai, Sabiha Trabelsi; Gauchez, Anne-Sophie; Coll, Jean-Luc; Charles, Julie; Hurbin, Amandine; Martel-Frachet, Véronique.
Afiliación
  • Castillo-Ferrer C; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; École Pratique des Hautes Études, PSL Research University, Paris, France.
  • Marguet T; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
  • Vanwonterghem L; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France.
  • Erbek S; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; École Pratique des Hautes Études, PSL Research University, Paris, France.
  • Chuffart F; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France.
  • Mouret S; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
  • Messai ST; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
  • Gauchez AS; Biology and Pathology Institute, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
  • Coll JL; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France.
  • Charles J; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; Dermatology, Allergology & Photobiology Department, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
  • Hurbin A; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France. Electronic address: amandine.hurbin@inserm.fr.
  • Martel-Frachet V; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Grenoble Alpes University, Grenoble, France; École Pratique des Hautes Études, PSL Research University, Paris, France.
J Invest Dermatol ; 144(2): 422-426.e8, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37580013
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Francia